scholarly journals Minimally Invasive Esophagectomy

2019 ◽  
Vol 37 (2) ◽  
pp. 93-100 ◽  
Author(s):  
Pieter Christiaan van der Sluis ◽  
Dimitrios Schizas ◽  
Theodore Liakakos ◽  
Richard van Hillegersberg
Keyword(s):  
Esophageal Cancer ◽  
Minimally Invasive ◽  
Minimally Invasive Esophagectomy ◽  
Invasive Procedure ◽  
Current Status ◽  
Invasive Esophagectomy ◽  
Laparoscopic Esophagectomy ◽  
Resectable Esophageal ◽  
Resectable Esophageal Cancer ◽  
Invasive Techniques

Minimally invasive esophagectomy (MIE) was introduced in the 1990s with the aim to decrease the rate of respiratory complications associated with thoracotomy, along with the benefits of reduced morbidity and a quicker return to normal activities provided by minimally invasive techniques. However, MIE is not routinely applied as a standard approach for esophageal cancer worldwide, due to the high technical complexity of this minimally invasive procedure. Therefore, the open transthoracic esophagectomy is considered to be the gold standard for resectable esophageal cancer worldwide nowadays. In this article, the current status of conventional MIE and robot-assisted minimally invasive thoraco-laparoscopic esophagectomy will be reviewed.

Minimally invasive esophagectomy

2021 ◽  
Keyword(s):  
Esophageal Cancer ◽  
Minimally Invasive ◽  
Minimally Invasive Esophagectomy ◽  
Respiratory Complications ◽  
Invasive Esophagectomy ◽  
Video Tutorial ◽  
Complex Procedure ◽  
Resectable Esophageal ◽  
Resectable Esophageal Cancer ◽  
Invasive Techniques

Minimally invasive esophagectomy is increasingly becoming the surgical treatment of choice for esophageal cancer. The goal of this technique is to reduce the rate of respiratory complications associated with thoracotomy while taking advantage of the benefits of reduced mortality associated with minimally invasive techniques. However, minimally invasive esophagectomy is still not considered the gold standard for resectable esophageal cancer worldwide because it is a highly technical and complex procedure. The goal of this video tutorial is to present an easy step-by-step approach to a minimally invasive esophagectomy and to address technical considerations and potential pitfalls.

scholarly journals Micronutrient Deficiencies Following Minimally Invasive Esophagectomy for Cancer

Nutrients ◽  
2020 ◽  
Vol 12 (3) ◽  
pp. 778
Author(s):  
Henricus J.B. Janssen ◽  
Laura F.C. Fransen ◽  
Jeroen E.H. Ponten ◽  
Grard A.P. Nieuwenhuijzen ◽  
Misha D.P. Luyer
Keyword(s):  
Minimally Invasive ◽  
Minimally Invasive Esophagectomy ◽  
Survival Rates ◽  
Micronutrient Deficiencies ◽  
Postoperative Evaluation ◽  
Invasive Esophagectomy ◽  
Resectable Esophageal ◽  
Resectable Esophageal Cancer ◽  
Esophagectomy For Cancer

Over the past decades, survival rates for patients with resectable esophageal cancer have improved significantly. Consequently, the sequelae of having a gastric conduit, such as development of micronutrient deficiencies, become increasingly apparent. This study investigated postoperative micronutrient trends in the follow-up of patients following a minimally invasive esophagectomy (MIE) for cancer. Patients were included if they had at least one postoperative evaluation of iron, ferritin, vitamins B1, B6, B12, D, folate or methylmalonic acid. Data were available in 83 of 95 patients. Of these, 78.3% (65/83) had at least one and 37.3% (31/83) had more than one micronutrient deficiency at a median of 6.1 months (interquartile range (IQR) 5.4–7.5) of follow-up. Similar to the results found in previous studies, most common deficiencies identified were: iron, vitamin B12 and vitamin D. In addition, folate deficiency and anemia were detected in a substantial amount of patients in this cohort. At 24.8 months (IQR 19.4–33.1) of follow-up, micronutrient deficiencies were still common, however, most deficiencies normalized following supplementation on indication. In conclusion, patients undergoing a MIE are at risk of developing micronutrient deficiencies as early as 6 up to 24 months after surgery and should therefore be routinely checked and supplemented when needed.

scholarly journals Current status of minimally invasive esophagectomy for esophageal cancer: Is it truly less invasive?

2018 ◽  
Vol 3 (2) ◽  
pp. 138-145 ◽  
Author(s):  
Taro Oshikiri ◽  
Gosuke Takiguchi ◽  
Susumu Miura ◽  
Nobuhisa Takase ◽  
Hiroshi Hasegawa ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Minimally Invasive ◽  
Minimally Invasive Esophagectomy ◽  
Current Status ◽  
Invasive Esophagectomy ◽  
Less Invasive

scholarly journals Emergency Laparoscopic Repair of Giant Left Diaphragmatic Hernia following Minimally Invasive Esophagectomy: Description of a Case and Review of the Literature

2018 ◽  
Vol 2018 ◽  
pp. 1-5
Author(s):  
Enrico Erdas ◽  
Gian Luigi Canu ◽  
Luca Gordini ◽  
Paolo Mura ◽  
Giulia Laconi ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Minimally Invasive ◽  
Diaphragmatic Hernia ◽  
Laparoscopic Repair ◽  
Minimally Invasive Esophagectomy ◽  
Laparoscopic Approach ◽  
Acute Setting ◽  
Invasive Esophagectomy ◽  
High Fraction ◽  
Invasive Techniques

Postoperative diaphragmatic hernia (PDH) is an increasingly reported complication of esophageal cancer surgery. PDH occurs more frequently when minimally invasive techniques are employed, but very little is known about its pathogenesis. Currently, no consensus exists concerning preventive measures and its management. A 71-year-old man underwent minimally invasive esophagectomy for esophageal cancer. Three months later, he developed a giant PDH, which was repaired by direct suture via laparoscopic approach. A hypertensive pneumothorax occurred during surgery. This complication was managed by the anaesthesiologist through a high fraction of inspired O2 and several recruitment manoeuvres. The patient remained free of hernia recurrence until he died of neoplastic cachexia 5 months later. Laparoscopic repair of PDH may be safe and effective even in the acute setting and in the case of massive herniation. However, surgeons and anaesthesiologists should be aware of the risk of intraoperative pneumothorax and be prepared to treat it promptly.

PS01.225: SINGLE HOLE PNEUMOPERITONEUM COMBINED WITH LAPAROSCOPIC RADICAL MASTECTOMY FOR ESOPHAGEAL CANCER

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 114-114
Author(s):  
Hua Tang ◽  
Kenan Huang ◽  
Xinyu Ding ◽  
Bin Wu ◽  
Zhifei Xu
Keyword(s):  
Esophageal Cancer ◽  
Blood Loss ◽  
Minimally Invasive ◽  
Operative Time ◽  
Conflicts Of Interest ◽  
Single Port ◽  
Minimally Invasive Esophagectomy ◽  
Radical Mastectomy ◽  
Invasive Esophagectomy ◽  
Laparoscopic Esophagectomy

Abstract Background Minimally invasive esophagectomy (MIE) has been an alternative treatment for esophageal cancer. The objective of this study is to evaluate the safety and feasibility of single-port CO2-inflatabled mediastinoscopic and laparoscopic esophagectomy for esophageal cancer. Methods Retrospective analysis of clinical data was performed on 12 patients with esophageal cancer who underwent a single-port CO2-inflatabled mediastinoscopic and laparoscopic esophagectomy by one surgical team in Shanghai Changzheng hospital. Recorded outcome measures included operative time, blood loss, length of hospital stay, and perioperative complications. Results No perioperative mortality, pulmonary infection, arrhythmia, recurrent laryngeal nerve (RLN) palsy and thoracic duct injury was observed in all patients. The operative time, intraoperative blood loss and pressure of CO2 was (219 ± 9.3)min, (26.3 ± 2.7)ml and (50.5 ± 4.6)mmHg. The mean number of dissected thoracic lymph nodes was 19 ± 1.5. One patient was converted to open surgery because of massive bleeding intraoperation. Two patients occurred postoperative anastomotic leakage. Conclusion A single-port CO2-inflatabled mediastinoscopic and laparoscopic esophagectomy provides safe and feasible approach to minimally invasive esophagectomy for patients with early esophageal cancer. Disclosure All authors have declared no conflicts of interest.

scholarly journals Evaluating early results of minimally invasive esophagectomy in abdominal surgery department II at National K Hospital

2020 ◽  
Vol 10 (4) ◽  
Author(s):  
Trong Tu Doan ◽  
Keyword(s):  
Esophageal Cancer ◽  
Abdominal Surgery ◽  
Minimally Invasive ◽  
Minimally Invasive Esophagectomy ◽  
Vocal Cord Palsy ◽  
Major Surgery ◽  
Invasive Esophagectomy ◽  
Early Results ◽  
Laparoscopic Esophagectomy ◽  
Surgery Department

Abstract Introduction: To evaluate early results of minimally invasive esophagectomy for esophageal cancer in Abdominal Surgery Department II at National K Hospital. Materials and methods: 130 patients with esophageal cancer underwent thoraco-laparoscopic esophagectomy - also was known as minimally invasive esophagectomy (MIE) - and gastric - tube reconstruction in Abdominal Surgery Department II at National K Hospital from 10/2017 to 7/2020. Descriptive study, patients were observed during hospitalization. Results: Mean age 56,8 ± 6,77 (min 35 - max 72), lymph node metastasis was 17,8%, T1 was 35,6%, T2 was 48,9% and T3 was 15,5%, squamous cell carcinoma accounted for 97,7%. Mean operative time was 226 ± 6 minutes, mean hospital stay was 15,2 ± 4,6 days, anastomosis leakage accounted for 6,1%, anastomosis stenosis was 15,3%, vocal cord palsy was 4,6% and pneumonia happened in 13,8%. Conclusions: Esophagectomy is a major surgery procedure that could be perform by thoraco-laparoscopy with good result.

Sign in / Sign up

Export Citation Format

Share Document